Pharmacological characterization of fluodipine: a new selective bradycardic agent Feb. 2, 1999 No Comments
Genetix and Cordis to develop angiogenic gene therapy products for cardiovascular disease Feb. 1, 1999 No Comments
Increased PKC activity activity and role for PKC-beta inhibitors in heart failure Feb. 1, 1999 No Comments
Genzyme collaborates with Canadian researchers to develop cardiovascular disease therapies Jan. 22, 1999 No Comments
RSS